Primary adrenal insufficiency

Patients should receive replacement therapy for life. Adherence to treatment is high, since noncompliance results in uncomfortable symptoms. Furthermore, patients know that noncompliance is potentially life-threatening.

Although the replacement doses try to replicate physiologic glucocorticoid and mineralocorticoid secretion, some patients complain of persistent fatigue and decreased well-being.